Team – Adragos Pharma https://adragos-pharma.com Your Global CDMO Mon, 27 Jul 2026 22:40:32 +0000 en-US hourly 1 https://wordpress.org/?v=7.0.3 https://adragos-pharma.com/wp-content/uploads/2024/04/cropped-Adragos-Pharma-Symbol-2024-32x32.png Team – Adragos Pharma https://adragos-pharma.com 32 32 Aggelos Karatzas https://adragos-pharma.com/team/aggelos-karatzas/ Wed, 20 Mar 2024 14:49:59 +0000 https://adragos.com/?post_type=team&p=1886 With over fifteen years of experience in R&D operations and seven years in his current position, Aggelos has played a pivotal role in the company’s success.

Aggelos holds a Doctoral Diploma in Pharmaceutical Technology and, after completing his MSc studies in Industrial Pharmacy, he started on a journey in the pharmaceutical industry. He began his career at the Formulation Department of Pharmathen and Alapis, swiftly advancing to the position of Head of Formulation Development at
Lamda Laboratories.

In 2016, Aggelos assumed the role of Managing Director, steering the company towards consistent growth and successful target achievement. In 2023, the company was acquired by Adragos Group, to ensure continuous improvement and success.

Aggelos envisions a future for Adragos Athens characterized by sustained growth and innovation. His strategic approach involves a relentless pursuit of excellence in new product development, creating additional assets for the Company and establishing solid partnerships, leveraging his expertise to position the company at the forefront of the industry.

]]>
Christina Doulgeri https://adragos-pharma.com/team/christina-doulgeri/ Fri, 19 Jun 2026 12:39:05 +0000 https://adragos-pharma.com/?post_type=team&p=25765 Mike Stradling https://adragos-pharma.com/team/mike-stradling/ Fri, 28 Feb 2025 10:41:48 +0000 https://adragos-pharma.com/?post_type=team&p=15817 Mike Stradling is the Global Head of Transformations. With extensive experience in sterile production and operational leadership, he is committed to driving our Swiss facility toward continued success and excellence.

For a more comprehensive look into Mike’s professional profile, connect with him on LinkedIn.

]]>
George Georgiadis https://adragos-pharma.com/team/george-georgiadis/ Mon, 22 Jun 2026 08:10:58 +0000 https://adragos-pharma.com/?post_type=team&p=25773 Anita Kettner https://adragos-pharma.com/team/anita-kettner/ Tue, 15 Jul 2025 14:40:00 +0000 https://adragos-pharma.com/?post_type=team&p=20579 Anita is the Head of Global Supply Chain, Procurement, and ESG at Adragos Pharma, bringing over 12 years of pharmaceutical industry experience spanning Internal Production, Operational Excellence, Procurement, and CMO Management. Passionate about sustainability, she combines deep supply chain and procurement expertise with a strong commitment to advancing ESG initiatives. Prior to joining Adragos Pharma, Anita played key roles driving strategic improvements across complex manufacturing and sourcing environments. Known for fostering a positive and inclusive work culture, she strives to empower teams and create an environment where employees feel valued and motivated to contribute to the company’s growth and sustainable success. Anita’s leadership supports Adragos Pharma’s mission to strengthen its industry position and achieve long-term growth goals.

]]>
Masanori Kurogome https://adragos-pharma.com/team/kurugome-masanori/ Wed, 20 Mar 2024 15:06:22 +0000 https://adragos.com/?post_type=team&p=1903 Kurogome serves as the site Head for Adragos, Kawagoe. After graduating from the Faculty of Pharmacy, he majored in analytical chemistry at graduate school. Following this he joined Aventis Pharma as a new graduate, which follows in the footsteps of Hoechst, the predecessor of Sanofi, who developed the “Hoechst-Wacker” method. He originally imagined himself in pharmaceutical analysis, such as quality control, but he was assigned to a production site at a factory. Through several years of experience in the production field he gained valuable insights which broaden his perspective and help him regarding decision making as the site head. In 2018 Kurogome started programming because he wanted to expand his skill set and explore new avenues of knowledge. It is Kurogome’s mission and goal to further enhance the value of Adragos Kawagoe and make it the only factory that cannot be replaced.

]]>
Moïses Ambea Onanga https://adragos-pharma.com/team/moises-ambea-onanga/ Tue, 23 Jun 2026 07:21:45 +0000 https://adragos-pharma.com/?post_type=team&p=25813 Moïses Ambea Onanga is Validation Division Manager in the pharmaceutical industry, with several years of experience in GMP-regulated environments. Through his roles at Adragos Pharma, Delpharm and Unither, he has developed strong expertise in the qualification and validation of equipment, systems and process utilities, as well as in maintaining the validated state.
His experience combines technical expertise, regulatory compliance and team leadership. He has contributed to the structuring and continuous improvement of validation activities, the management of deviations and change controls, risk assessments, and the preparation of audits and regulatory inspections. Working closely with cross-functional teams, he supports robust validation practices aligned with both GMP expectations and operational realities.
With a background in process engineering and biotechnological processes, Moïses brings a rigorous, field-oriented and collaborative approach to validation. He is committed to building inspection-ready quality systems that support operational performance, long-term compliance and team development.
]]>
Freddy Waterloos https://adragos-pharma.com/team/freddy-waterloos/ Fri, 26 Jun 2026 09:34:44 +0000 https://adragos-pharma.com/?post_type=team&p=25891 Idir Zaïdi https://adragos-pharma.com/team/idir-zaidi/ Tue, 30 Jun 2026 10:51:53 +0000 https://adragos-pharma.com/?post_type=team&p=25975 Idir Zaidi is Head of HSES at the Maisons-Alfort site, leading the site’s Health, Safety, Environment, and operational safety agenda. With over 10 years of experience in the pharmaceutical
industry, Idir has held HSE roles at GSK and Sanofi, spanning both local and global responsibilities. Dedicated to advancing safety culture, elevating HSE standards, and driving continuous improvement.

]]>
Keizo Yanagisawa https://adragos-pharma.com/team/keizo-yanagisawa/ Wed, 20 Mar 2024 15:08:43 +0000 https://adragos.com/?post_type=team&p=1909 Mr. Keizo Yanagisawa joined Adragos Pharma K. K. in 2022 as President and Representative Director and was appointed as President and Representative Director of Kawagoe Pharma K. K. in 2023 when Adragos Pharma GmbH acquired the Kawagoe facility from Sanofi. Keizo has almost 20 years of experience in the Pharma industry, particularly in shaping, driving strategy, and building successful business models of CDMO in Japan.

Between 2010 and 2023, Keizo was Representative Director of Haupt Pharma Toride, managing the first German CMO in Japan and leading a rapidly growing organization together with Mr. Prange, who is one of the shareholders of Adragos Pharma GmbH. Prior to Haupt Pharma Toride, he was at MSD Japan for 5 years, where he was a seasoned Senior Director of Strategy and Management for Research and Development Institutes in Tsukuba. Keizo had previously been in various positions of increasing responsibility at Kobe Steel including Senior Manager for Corporate Planning and Steel Products Export.

Keizo received his Bachelor of Arts focusing on the History of the banking system in England during the Industrial Revolution from Tohoku University in Japan. 

Keizo also holds an MBA in Executive MBA at Kellogg School of Management at Northwestern University in Evanston, USA.

]]>